Wong et al., 2003 - Google Patents
Fibrin-based biomaterials to deliver human growth factorsWong et al., 2003
- Document ID
- 3436852497416288058
- Author
- Wong C
- Inman E
- Spaethe R
- Helgerson S
- Publication year
- Publication venue
- Thrombosis and haemostasis
External Links
Snippet
Fibrin-based biomaterial preparations can be used as provisional growth matrices for cells important in tissue repair during wound healing in vivo. Their efficacy can be enhanced by including bioactive agents that promote specific cellular responses. This study examined the …
- 239000003102 growth factor 0 title abstract description 98
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/25—Peptides having up to 20 amino acids in a defined sequence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION, OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS, OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/412—Tissue-regenerating or healing or proliferative agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/44—Vessels; Vascular smooth muscle cells; Endothelial cells; Endothelial progenitor cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Wong et al. | Fibrin-based biomaterials to deliver human growth factors | |
| Nanney et al. | Calreticulin enhances porcine wound repair by diverse biological effects | |
| Piccin et al. | Platelet gel: a new therapeutic tool with great potential | |
| Grinnell et al. | Transforming growth factor β stimulates fibroblast–collagen matrix contraction by different mechanisms in mechanically loaded and unloaded matrices | |
| Bootle-Wilbraham et al. | Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro | |
| Jeziorska et al. | Local neovascularization and cellular composition within vulnerable regions of atherosclerotic plaques of human carotid arteries | |
| Zcharia et al. | Heparanase accelerates wound angiogenesis and wound healing in mouse and rat models | |
| Philp et al. | Thymosin β4 and a synthetic peptide containing its actin‐binding domain promote dermal wound repair in db/db diabetic mice and in aged mice | |
| Naito et al. | Smooth muscle cell outgrowth stimulated by fibrin degradation products: the potential role of fibrin fragment E in restenosis and atherogenesis | |
| AU679795B2 (en) | Methods for tissue embedding and tissue culturing | |
| Chavakis et al. | Regulation of neovascularization by human neutrophil peptides (α‐defensins): a link between inflammation and angiogenesis | |
| US6723302B1 (en) | Model for cell migration and use thereof | |
| AU769806B2 (en) | Methods of inhibiting ectopic calcification | |
| Kannemeier et al. | Factor VII activating protease (FSAP) inhibits growth factor‐mediated cell proliferation and migration of vascular smooth muscle cells. | |
| Gorodetsky et al. | Haptotactic and growth stimulatory effects of fibrin (ogen) and thrombin on cultured fibroblasts | |
| CA2184705A1 (en) | In vitro angiogenesis assay | |
| Shi et al. | Heparan sulfate proteoglycan promotes fibroblast growth factor-2 function for ischemic heart repair | |
| US20100111931A1 (en) | Agents, Which Inhibit Apoptosis in Cells that are Involved in Wound Healing | |
| US20020110554A1 (en) | Tissue sealant compositions | |
| CN109844529A (en) | The skin wound not healed for identification and the method for monitoring skin wound healing | |
| EP1073485A1 (en) | Fully recombinant tissue sealant compositions | |
| Harmon et al. | Effects of fibrin pad hemostat on the wound healing process in vivo and in vitro | |
| Zeng et al. | Fluorescently conjugated annular fibrin clot for multiplexed real-time digestion analysis | |
| Kiefer et al. | A versatile in vitro assay for investigating angiogenesis of the heart | |
| Garnier et al. | Factor XII protects neurons from apoptosis by epidermal and hepatocyte growth factor receptor‐dependent mechanisms |